Penaeus chinensis breed Huanghai No. 1 chromosome 40, ASM1920278v2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Dendrobranchiata; Penaeoidea; Penaeidae; Penaeus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM032965.1.\nAssembly name: ASM1920278v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Yellow Sea Fisheries Research\nInstitute, Chinese Academy of Fishery Sciences on 2021/07/13. The\noriginal whole-genome shotgun project has the accession\nJAGKSU000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Yellow Sea Fisheries Research Institute,\n Chinese Academy of Fishery Sciences\nAssembly Date :: 2020\nAssembly Method :: FALCON-Unzip v. MAY-2020\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 150.0x\nSequencing Technology :: PacBio Sequel\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Penaeus chinensis Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
conservation base of Haifeng Aquaculture Co., Ltd.
Derived by automated computational analysis using gene prediction method: Gnomon.
basic proline-rich protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
basic proline-rich protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
basic proline-rich protein-like isoform X2
basic proline-rich protein-like isoform X1
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like
COORDINATES: polyA evidence [ECO:0006239]
rho guanine nucleotide exchange factor 11-like
similar to RNA sequence (same species):INSD:GIYE01013090.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 460 bases not found in genome assembly
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 460 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC125047034, transcript variant X1
uncharacterized LOC125047034, transcript variant X2
uncharacterized LOC125047034, transcript variant X9
uncharacterized LOC125047034, transcript variant X5
uncharacterized LOC125047034, transcript variant X3
uncharacterized LOC125047034, transcript variant X7
uncharacterized LOC125047034, transcript variant X8
uncharacterized LOC125047034, transcript variant X6
uncharacterized LOC125047034, transcript variant X4
uncharacterized LOC125047034, transcript variant X10
uncharacterized protein LOC125047034 isoform X1
uncharacterized protein LOC125047034 isoform X2
uncharacterized protein LOC125047034 isoform X3
uncharacterized LOC125047117, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
uncharacterized LOC125047117, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC125047117 isoform X2
uncharacterized protein LOC125047117 isoform X1
BTB/POZ domain-containing protein 9-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
BTB/POZ domain-containing protein 9-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
BTB/POZ domain-containing protein 9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
dopamine receptor 1-like, transcript variant X2
dopamine receptor 1-like, transcript variant X1
irregular chiasm C-roughest protein-like, transcript variant X2
irregular chiasm C-roughest protein-like, transcript variant X1
irregular chiasm C-roughest protein-like isoform X2
irregular chiasm C-roughest protein-like isoform X1
39S ribosomal protein L28, mitochondrial-like
PRELI domain-containing protein 2-like, transcript variant X3
PRELI domain-containing protein 2-like, transcript variant X4
PRELI domain-containing protein 2-like, transcript variant X1
PRELI domain-containing protein 2-like, transcript variant X2
PRELI domain-containing protein 2-like, transcript variant X5
PRELI domain-containing protein 2-like, transcript variant X6
uncharacterized LOC125047087, transcript variant X3
uncharacterized LOC125047087, transcript variant X2
uncharacterized LOC125047087, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 79% coverage of the annotated genomic feature by RNAseq alignments
dynein axonemal intermediate chain 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments
glyoxylate/hydroxypyruvate reductase A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60% coverage of the annotated genomic feature by RNAseq alignments
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
putative gamma-glutamylcyclotransferase CG2811, transcript variant X4
putative gamma-glutamylcyclotransferase CG2811, transcript variant X2
putative gamma-glutamylcyclotransferase CG2811, transcript variant X3
putative gamma-glutamylcyclotransferase CG2811, transcript variant X1
putative gamma-glutamylcyclotransferase CG2811 isoform X1
putative gamma-glutamylcyclotransferase CG2811 isoform X2
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X1
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X2
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like isoform X2
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like isoform X1
2-oxoisovalerate dehydrogenase subunit beta, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
probable G-protein coupled receptor Mth-like 3, transcript variant X2
probable G-protein coupled receptor Mth-like 3, transcript variant X1
probable G-protein coupled receptor Mth-like 3 isoform X2
probable G-protein coupled receptor Mth-like 3 isoform X1
uncharacterized LOC125047220, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC125047220, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
probable G-protein coupled receptor Mth-like 3, transcript variant X3
G-protein coupled receptor Mth2-like isoform X1
probable G-protein coupled receptor Mth-like 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
probable G-protein coupled receptor Mth-like 3 isoform X3
uncharacterized LOC125047303, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC125047303, transcript variant X3
uncharacterized LOC125047303, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized protein LOC125047303 isoform X2
uncharacterized protein LOC125047303 isoform X3
uncharacterized protein LOC125047303 isoform X1
4F2 cell-surface antigen heavy chain-like, transcript variant X1
4F2 cell-surface antigen heavy chain-like, transcript variant X2
4F2 cell-surface antigen heavy chain-like isoform X2
4F2 cell-surface antigen heavy chain-like isoform X1
T-cell activation inhibitor, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77% coverage of the annotated genomic feature by RNAseq alignments
probable G-protein coupled receptor Mth-like 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: fanconi-associated nuclease 1-like
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X7
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X19
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X17
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X16
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X18
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X2
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X15
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X12
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X9
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X5
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X11
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X6
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X3
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X1
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X14
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X8
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X4
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X13
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X10
cytoplasmic dynein 1 intermediate chain 2-like isoform X18
cytoplasmic dynein 1 intermediate chain 2-like isoform X16
cytoplasmic dynein 1 intermediate chain 2-like isoform X15
cytoplasmic dynein 1 intermediate chain 2-like isoform X17
cytoplasmic dynein 1 intermediate chain 2-like isoform X6
cytoplasmic dynein 1 intermediate chain 2-like isoform X12
cytoplasmic dynein 1 intermediate chain 2-like isoform X14
cytoplasmic dynein 1 intermediate chain 2-like isoform X11
cytoplasmic dynein 1 intermediate chain 2-like isoform X8
cytoplasmic dynein 1 intermediate chain 2-like isoform X4
cytoplasmic dynein 1 intermediate chain 2-like isoform X10
cytoplasmic dynein 1 intermediate chain 2-like isoform X5
cytoplasmic dynein 1 intermediate chain 2-like isoform X2
cytoplasmic dynein 1 intermediate chain 2-like isoform X1
cytoplasmic dynein 1 intermediate chain 2-like isoform X13
cytoplasmic dynein 1 intermediate chain 2-like isoform X9
cytoplasmic dynein 1 intermediate chain 2-like isoform X7
cytoplasmic dynein 1 intermediate chain 2-like isoform X3
cytoplasmic dynein 1 intermediate chain 2-like, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytoplasmic dynein 1 intermediate chain-like isoform X19
regulator of G-protein signaling 9-binding protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
regulator of G-protein signaling 9-binding protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
regulator of G-protein signaling 9-binding protein-like
60S ribosomal protein L6-like, transcript variant X2
60S ribosomal protein L6-like, transcript variant X4
60S ribosomal protein L6-like, transcript variant X3
60S ribosomal protein L6-like, transcript variant X1
60S ribosomal protein L6-like isoform X1
60S ribosomal protein L6-like isoform X2
serine/threonine-protein phosphatase PGAM5, mitochondrial-like, transcript variant X1
serine/threonine-protein phosphatase PGAM5, mitochondrial-like, transcript variant X2
serine/threonine-protein phosphatase PGAM5, mitochondrial-like isoform X1
serine/threonine-protein phosphatase PGAM5, mitochondrial-like isoform X2
uncharacterized LOC125047063, transcript variant X4
uncharacterized LOC125047063, transcript variant X6
uncharacterized LOC125047063, transcript variant X7
uncharacterized LOC125047063, transcript variant X5
uncharacterized LOC125047063, transcript variant X2
uncharacterized LOC125047063, transcript variant X3
uncharacterized LOC125047063, transcript variant X1
uncharacterized LOC125046986, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125046986, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125046986, transcript variant X2
uncharacterized protein LOC125046986 isoform X2
uncharacterized protein LOC125046986 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
uncharacterized LOC125047237, transcript variant X1
uncharacterized LOC125047237, transcript variant X2
uncharacterized protein LOC125047237 isoform X1
uncharacterized protein LOC125047237 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125047253, transcript variant X2
uncharacterized LOC125047253, transcript variant X1
uncharacterized LOC125047205, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC125047205, transcript variant X2
uncharacterized LOC125047205, transcript variant X1
uncharacterized LOC125047043, transcript variant X1
uncharacterized LOC125047043, transcript variant X3
uncharacterized LOC125047043, transcript variant X5
uncharacterized LOC125047043, transcript variant X2
uncharacterized LOC125047043, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
adenylate cyclase type 9-like, transcript variant X2
adenylate cyclase type 9-like, transcript variant X3
adenylate cyclase type 9-like, transcript variant X4
adenylate cyclase type 9-like, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3-like
ankyrin repeat and IBR domain-containing protein 1-like, transcript variant X5
ankyrin repeat and IBR domain-containing protein 1-like, transcript variant X1
ankyrin repeat and IBR domain-containing protein 1-like, transcript variant X4
ankyrin repeat and IBR domain-containing protein 1-like, transcript variant X2
ankyrin repeat and IBR domain-containing protein 1-like, transcript variant X3
ankyrin repeat and IBR domain-containing protein 1-like isoform X2
ankyrin repeat and IBR domain-containing protein 1-like isoform X1
transcriptional regulator ATRX-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
transcriptional regulator ATRX-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
transcriptional regulator ATRX-like isoform X1
transcriptional regulator ATRX-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Golgi phosphoprotein 3 homolog sauron-like, transcript variant X1
Golgi phosphoprotein 3 homolog sauron-like, transcript variant X2
Golgi phosphoprotein 3 homolog sauron-like
uncharacterized LOC125047026, transcript variant X1
uncharacterized LOC125047026, transcript variant X2
regulator of G-protein signaling 10-like, transcript variant X3
regulator of G-protein signaling 10-like, transcript variant X1
regulator of G-protein signaling 10-like, transcript variant X2
regulator of G-protein signaling 10-like isoform X2
regulator of G-protein signaling 10-like isoform X1
glycine, alanine and asparagine-rich protein-like, transcript variant X1
glycine, alanine and asparagine-rich protein-like, transcript variant X3
glycine, alanine and asparagine-rich protein-like, transcript variant X2
glycine, alanine and asparagine-rich protein-like isoform X1
AF4/FMR2 family member lilli-like isoform X2
microsomal glutathione S-transferase 3-like
microsomal glutathione S-transferase 3-like, transcript variant X1
microsomal glutathione S-transferase 3-like isoform X1
microsomal glutathione S-transferase 3-like, transcript variant X2
microsomal glutathione S-transferase 3-like, transcript variant X3
microsomal glutathione S-transferase 3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
TGF-beta receptor type-1-like, transcript variant X1
TGF-beta receptor type-1-like, transcript variant X2
TGF-beta receptor type-1-like, transcript variant X3
TGF-beta receptor type-1-like isoform X2
TGF-beta receptor type-1-like isoform X3
TGF-beta receptor type-1-like isoform X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
basic salivary proline-rich protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
gem-associated protein 2-like, transcript variant X1
gem-associated protein 2-like, transcript variant X2
transcription elongation factor A N-terminal and central domain-containing protein 2-like, transcript variant X1
transcription elongation factor A N-terminal and central domain-containing protein 2-like, transcript variant X2
transcription elongation factor A N-terminal and central domain-containing protein 2-like
COP9 signalosome complex subunit 5-like, transcript variant X1
COP9 signalosome complex subunit 5-like, transcript variant X2
lysosomal-associated transmembrane protein 4A-like, transcript variant X6
lysosomal-associated transmembrane protein 4A-like, transcript variant X5
lysosomal-associated transmembrane protein 4A-like, transcript variant X4
lysosomal-associated transmembrane protein 4A-like, transcript variant X3
lysosomal-associated transmembrane protein 4A-like, transcript variant X7
lysosomal-associated transmembrane protein 4A-like, transcript variant X2
lysosomal-associated transmembrane protein 4A-like, transcript variant X1
tetraspanning orphan receptor-like isoform X4
tetraspanning orphan receptor-like isoform X3
tetraspanning orphan receptor-like isoform X2
tetraspanning orphan receptor-like isoform X1
lysosomal-associated transmembrane protein 4A-like isoform X5
lys-63-specific deubiquitinase BRCC36-like, transcript variant X1
lys-63-specific deubiquitinase BRCC36-like, transcript variant X2
lys-63-specific deubiquitinase BRCC36-like
mitochondrial import inner membrane translocase subunit Tim29-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate receptor ionotropic, kainate 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45% coverage of the annotated genomic feature by RNAseq alignments
protein trapped in endoderm-1-like, transcript variant X3
protein trapped in endoderm-1-like, transcript variant X2
protein trapped in endoderm-1-like, transcript variant X1
protein trapped in endoderm-1-like isoform X1
protein trapped in endoderm-1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
protein trapped in endoderm-1-like isoform X2
synaptotagmin-15-like, transcript variant X2
synaptotagmin-15-like, transcript variant X1
neuronal cell adhesion molecule-like, transcript variant X1
neuronal cell adhesion molecule-like, transcript variant X2
neuronal cell adhesion molecule-like isoform X1
neuronal cell adhesion molecule-like isoform X2
26S proteasome regulatory subunit 6B-like
adenine phosphoribosyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adenine phosphoribosyltransferase-like isoform X1
adenine phosphoribosyltransferase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
adenine phosphoribosyltransferase-like, transcript variant X3
adenine phosphoribosyltransferase-like, transcript variant X4
adenine phosphoribosyltransferase-like isoform X2
neo-calmodulin-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neo-calmodulin-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neo-calmodulin-like, transcript variant X1
pollen-specific leucine-rich repeat extensin-like protein 4
uncharacterized LOC125047186, transcript variant X1
uncharacterized LOC125047186, transcript variant X2
uncharacterized protein LOC125047186 isoform X2
uncharacterized protein LOC125047186 isoform X1
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X1
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X2
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X4
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X3
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like isoform X1
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like isoform X2
uncharacterized LOC125047218, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125047218, transcript variant X1
uncharacterized protein LOC125047218 isoform X2
uncharacterized protein LOC125047218 isoform X1
sodium/hydrogen exchanger 9B2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
sodium/hydrogen exchanger 9B2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125047322, transcript variant X2
uncharacterized LOC125047322, transcript variant X1
uncharacterized protein LOC125047322 isoform X1
uncharacterized protein LOC125047322 isoform X2
muscle calcium channel subunit alpha-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
voltage-dependent calcium channel type D subunit alpha-1-like
DNA methyltransferase 1-associated protein 1-like
phosphoribosyl pyrophosphate synthase-associated protein 2-like, transcript variant X2
phosphoribosyl pyrophosphate synthase-associated protein 2-like, transcript variant X1
phosphoribosyl pyrophosphate synthase-associated protein 2-like, transcript variant X3
phosphoribosyl pyrophosphate synthase-associated protein 2-like, transcript variant X5
phosphoribosyl pyrophosphate synthase-associated protein 2-like, transcript variant X6
phosphoribosyl pyrophosphate synthase-associated protein 2-like, transcript variant X4
phosphoribosyl pyrophosphate synthase-associated protein 1-like isoform X1
phosphoribosyl pyrophosphate synthase-associated protein 1-like isoform X2
phosphoribosyl pyrophosphate synthase-associated protein 2-like isoform X3
phosphoribosyl pyrophosphate synthase-associated protein 2-like isoform X4
m7GpppN-mRNA hydrolase-like, transcript variant X1
m7GpppN-mRNA hydrolase-like, transcript variant X2
ATP-binding cassette sub-family D member 2-like
uncharacterized LOC125047325, transcript variant X2
uncharacterized LOC125047325, transcript variant X1
uncharacterized protein LOC125047325 isoform X2
uncharacterized protein LOC125047325 isoform X1
serine/threonine-protein kinase SIK3-like, transcript variant X3
serine/threonine-protein kinase SIK3-like, transcript variant X2
serine/threonine-protein kinase SIK3-like, transcript variant X1
serine/threonine-protein kinase SIK3-like, transcript variant X4
serine/threonine-protein kinase SIK3 homolog isoform X1
serine/threonine-protein kinase SIK3-like isoform X3
serine/threonine-protein kinase SIK3-like isoform X4
serine/threonine-protein kinase SIK3 homolog isoform X2
guanine nucleotide-binding protein-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
malignant T-cell-amplified sequence 1 homolog, transcript variant X1
malignant T-cell-amplified sequence 1 homolog, transcript variant X2
malignant T-cell-amplified sequence 1 homolog isoform X1
malignant T-cell-amplified sequence 1 homolog isoform X2
transcription initiation factor TFIID subunit 11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
transcription initiation factor TFIID subunit 11-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transcription initiation factor TFIID subunit 11-like
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
high-affinity lysophosphatidic acid receptor-like, transcript variant X5
high-affinity lysophosphatidic acid receptor-like, transcript variant X1
high-affinity lysophosphatidic acid receptor-like, transcript variant X2
high-affinity lysophosphatidic acid receptor-like, transcript variant X6
high-affinity lysophosphatidic acid receptor-like, transcript variant X4
high-affinity lysophosphatidic acid receptor-like, transcript variant X3
uncharacterized protein LOC125047185 isoform X2
uncharacterized protein LOC125047185 isoform X3
high-affinity lysophosphatidic acid receptor-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
KRAB-A domain-containing protein 2-like, transcript variant X3
KRAB-A domain-containing protein 2-like, transcript variant X1
KRAB-A domain-containing protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins
translationally-controlled tumor protein homolog
85/88 kDa calcium-independent phospholipase A2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
85/88 kDa calcium-independent phospholipase A2-like, transcript variant X2
85/88 kDa calcium-independent phospholipase A2-like isoform X1
85/88 kDa calcium-independent phospholipase A2-like isoform X2
85/88 kDa calcium-independent phospholipase A2-like, transcript variant X3
85/88 kDa calcium-independent phospholipase A2-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
general transcription factor II-I repeat domain-containing protein 2-like
striatin-interacting protein 1 homolog, transcript variant X1
striatin-interacting protein 1 homolog, transcript variant X2
striatin-interacting protein 1 homolog isoform X1
striatin-interacting protein 1 homolog isoform X2
putative inorganic phosphate cotransporter, transcript variant X1
putative inorganic phosphate cotransporter, transcript variant X2
putative inorganic phosphate cotransporter isoform X1
putative inorganic phosphate cotransporter isoform X2
putative inorganic phosphate cotransporter
COORDINATES: nucleotide motif:Rfam:12.0:RF00319
chromosome alignment-maintaining phosphoprotein 1-like
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
uncharacterized LOC125047279, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC125047279, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
phytanoyl-CoA dioxygenase, peroxisomal-like, transcript variant X2
phytanoyl-CoA dioxygenase, peroxisomal-like, transcript variant X1
phytanoyl-CoA dioxygenase, peroxisomal-like, transcript variant X3
phytanoyl-CoA dioxygenase, peroxisomal-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
discoidin domain-containing receptor 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transfer RNA arginine (anticodon CCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
collagen alpha-1(XI) chain-like, transcript variant X1
collagen alpha-1(XI) chain-like, transcript variant X2
collagen alpha-1(XI) chain-like isoform X1
collagen alpha-1(XVIII) chain-like isoform X2
serine/arginine repetitive matrix protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamine (anticodon UUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
peritrophin-44-like, transcript variant X2
peritrophin-44-like, transcript variant X1
uncharacterized LOC125046982, transcript variant X1
uncharacterized protein LOC125046982 isoform X1
uncharacterized LOC125046982, transcript variant X2
uncharacterized protein LOC125046982 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 1-like, transcript variant X6
potassium voltage-gated channel subfamily KQT member 1-like, transcript variant X5
potassium voltage-gated channel subfamily KQT member 1-like, transcript variant X7
potassium voltage-gated channel subfamily KQT member 1-like, transcript variant X4
potassium voltage-gated channel subfamily KQT member 1-like, transcript variant X3
potassium voltage-gated channel subfamily KQT member 1-like, transcript variant X1
potassium voltage-gated channel subfamily KQT member 1-like, transcript variant X2
potassium voltage-gated channel subfamily KQT member 1-like isoform X6
potassium voltage-gated channel subfamily KQT member 1-like isoform X5
potassium voltage-gated channel subfamily KQT member 1-like isoform X7
potassium voltage-gated channel subfamily KQT member 1-like isoform X4
potassium voltage-gated channel subfamily KQT member 1-like isoform X3
potassium voltage-gated channel subfamily KQT member 1-like isoform X1
potassium voltage-gated channel subfamily KQT member 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type 4-like
similar to RNA sequence (same species):INSD:GHUY01009674.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 1596 bases not found in genome assembly
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 1261 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
putative carbonic anhydrase-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C7orf26 homolog, transcript variant X1
uncharacterized protein C7orf26 homolog, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
LOW QUALITY PROTEIN: cyclin-G-associated kinase-like
uncharacterized LOC125047198, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125047198, transcript variant X2
uncharacterized LOC125047019, transcript variant X2
uncharacterized LOC125047019, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
X-ray repair cross-complementing protein 6-like, transcript variant X2
X-ray repair cross-complementing protein 6-like, transcript variant X1
X-ray repair cross-complementing protein 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 41% coverage of the annotated genomic feature by RNAseq alignments
anther-specific proline-rich protein APG-like
endoplasmic reticulum junction formation protein lunapark-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
sodium/hydrogen exchanger 9B2-like, transcript variant X4
sodium/hydrogen exchanger 9B2-like, transcript variant X3
sodium/hydrogen exchanger 9B2-like isoform X1
sodium/hydrogen exchanger 9B2-like isoform X2
sodium/hydrogen exchanger 9B2-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/arginine repetitive matrix protein 1-like
dual specificity mitogen-activated protein kinase kinase 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
dual specificity mitogen-activated protein kinase kinase 6-like, transcript variant X1
dual specificity mitogen-activated protein kinase kinase 6-like
trafficking protein particle complex subunit 6b-like
extracellular signal-regulated kinase 2-like
cytochrome c oxidase subunit 6B2-like, transcript variant X2
cytochrome c oxidase subunit 6B2-like, transcript variant X3
cytochrome c oxidase subunit 6B2-like, transcript variant X4
cytochrome c oxidase subunit 6B2-like, transcript variant X1
cytochrome c oxidase subunit 6B2-like isoform X1
cytochrome c oxidase subunit 6B2-like isoform X2
N-acetylneuraminate 9-O-acetyltransferase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
vacuolar protein sorting-associated protein 35-like
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: vacuolar protein sorting-associated protein 35-like
uncharacterized LOC125047201, transcript variant X1
uncharacterized protein LOC125047201 isoform X1
uncharacterized LOC125047201, transcript variant X2
uncharacterized protein LOC125047201 isoform X2
heterogeneous nuclear ribonucleoprotein A3 homolog 2-like
glycine-rich cell wall structural protein 2-like
carbohydrate sulfotransferase 10-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
carbohydrate sulfotransferase 10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA isoleucine (anticodon UAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC125047314, transcript variant X2
uncharacterized LOC125047314, transcript variant X1
uncharacterized protein LOC125047314 isoform X2
uncharacterized protein LOC125047314 isoform X1
gamma-soluble NSF attachment protein-like
protein scarlet-like, transcript variant X2
protein scarlet-like, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
protein white-like, transcript variant X1
protein white-like, transcript variant X2
DNA polymerase iota-like, transcript variant X2
ribosomal RNA processing protein 36 homolog
DNA polymerase iota-like, transcript variant X1
histone-lysine N-methyltransferase 2B-like, transcript variant X7
histone-lysine N-methyltransferase 2B-like, transcript variant X3
histone-lysine N-methyltransferase 2B-like, transcript variant X5
histone-lysine N-methyltransferase 2B-like, transcript variant X6
histone-lysine N-methyltransferase 2B-like, transcript variant X2
histone-lysine N-methyltransferase 2B-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
histone-lysine N-methyltransferase 2B-like, transcript variant X1
uncharacterized protein LOC125047224 isoform X3
uncharacterized protein LOC125047224 isoform X2
uncharacterized protein LOC125047224 isoform X1
histone-lysine N-methyltransferase 2B-like isoform X4
uncharacterized LOC125047225, transcript variant X1
uncharacterized LOC125047225, transcript variant X2
uncharacterized LOC125047225, transcript variant X3
death-associated inhibitor of apoptosis 2-like, transcript variant X4
death-associated inhibitor of apoptosis 2-like, transcript variant X3
death-associated inhibitor of apoptosis 2-like, transcript variant X1
death-associated inhibitor of apoptosis 2-like, transcript variant X2
death-associated inhibitor of apoptosis 2-like
39S ribosomal protein L41, mitochondrial-like
toll-like receptor 13, transcript variant X1
toll-like receptor 13, transcript variant X3
toll-like receptor 13, transcript variant X2
insulin-like growth factor-binding protein complex acid labile subunit isoform X1
PDZ domain-containing protein GIPC1-like, transcript variant X1
PDZ domain-containing protein GIPC1-like isoform X1
PDZ domain-containing protein GIPC1-like, transcript variant X2
PDZ domain-containing protein GIPC1-like isoform X2
LOW QUALITY PROTEIN: dnaJ homolog subfamily C member 16-like
KAT8 regulatory NSL complex subunit 1-like, transcript variant X1
KAT8 regulatory NSL complex subunit 1-like, transcript variant X2
KAT8 regulatory NSL complex subunit 1-like isoform X2
KAT8 regulatory NSL complex subunit 1-like isoform X1
long-chain specific acyl-CoA dehydrogenase, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125046989, transcript variant X2
uncharacterized LOC125046989, transcript variant X3
uncharacterized LOC125046989, transcript variant X1
uncharacterized protein LOC125046989 isoform X3
uncharacterized protein LOC125046989 isoform X1
uncharacterized protein LOC125046989 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
sulfide:quinone oxidoreductase, mitochondrial-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
sulfide:quinone oxidoreductase, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
sulfide:quinone oxidoreductase, mitochondrial-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
sulfide:quinone oxidoreductase, mitochondrial-like
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X28
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X26
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X15
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X25
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X23
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X24
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X20
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X13
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X8
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X32
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X21
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X5
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X18
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X4
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X19
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X17
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X22
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X16
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X14
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X7
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X11
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X3
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X6
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X9
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X10
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X29
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X27
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X12
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X1
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X2
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X30
voltage-dependent calcium channel type A subunit alpha-1-like isoform X28
voltage-dependent calcium channel type A subunit alpha-1-like isoform X26
voltage-dependent calcium channel type A subunit alpha-1-like isoform X15
voltage-dependent calcium channel type A subunit alpha-1-like isoform X25
voltage-dependent calcium channel type A subunit alpha-1-like isoform X23
voltage-dependent calcium channel type A subunit alpha-1-like isoform X24
voltage-dependent calcium channel type A subunit alpha-1-like isoform X20
voltage-dependent calcium channel type A subunit alpha-1-like isoform X13
voltage-dependent calcium channel type A subunit alpha-1-like isoform X8
voltage-dependent calcium channel type A subunit alpha-1-like isoform X32
voltage-dependent calcium channel type A subunit alpha-1-like isoform X21
voltage-dependent calcium channel type A subunit alpha-1-like isoform X5
voltage-dependent calcium channel type A subunit alpha-1-like isoform X18
voltage-dependent calcium channel type A subunit alpha-1-like isoform X4
voltage-dependent calcium channel type A subunit alpha-1-like isoform X19
voltage-dependent calcium channel type A subunit alpha-1-like isoform X17
voltage-dependent calcium channel type A subunit alpha-1-like isoform X22
voltage-dependent calcium channel type A subunit alpha-1-like isoform X16
voltage-dependent calcium channel type A subunit alpha-1-like isoform X14
voltage-dependent calcium channel type A subunit alpha-1-like isoform X7
voltage-dependent calcium channel type A subunit alpha-1-like isoform X11
voltage-dependent calcium channel type A subunit alpha-1-like isoform X3
voltage-dependent calcium channel type A subunit alpha-1-like isoform X6
voltage-dependent calcium channel type A subunit alpha-1-like isoform X9
voltage-dependent calcium channel type A subunit alpha-1-like isoform X10
voltage-dependent calcium channel type A subunit alpha-1-like isoform X29
voltage-dependent calcium channel type A subunit alpha-1-like isoform X27
voltage-dependent calcium channel type A subunit alpha-1-like isoform X12
voltage-dependent calcium channel type A subunit alpha-1-like isoform X1
voltage-dependent calcium channel type A subunit alpha-1-like isoform X2
voltage-dependent calcium channel type A subunit alpha-1-like isoform X30
voltage-dependent calcium channel type A subunit alpha-1-like, transcript variant X31
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
voltage-dependent calcium channel type A subunit alpha-1-like isoform X31
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
arf-GAP with dual PH domain-containing protein 1-like, transcript variant X3
arf-GAP with dual PH domain-containing protein 1-like isoform X3
arf-GAP with dual PH domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
arf-GAP with dual PH domain-containing protein 1-like isoform X2
arf-GAP with dual PH domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
arf-GAP with dual PH domain-containing protein 1-like isoform X1
DNA helicase MCM8-like, transcript variant X1
DNA helicase MCM8-like, transcript variant X2
uncharacterized LOC125047008, transcript variant X2
uncharacterized LOC125047008, transcript variant X1
uncharacterized protein LOC125047008 isoform X2
uncharacterized protein LOC125047008 isoform X1
uncharacterized LOC125047008, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
uncharacterized LOC125047180, transcript variant X2
uncharacterized LOC125047180, transcript variant X1
uncharacterized protein LOC125047180 isoform X1
uncharacterized protein LOC125047180 isoform X2
eukaryotic translation initiation factor 4 gamma 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
glycine-rich protein 5-like, transcript variant X2
glycine-rich protein 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins
uncharacterized LOC125047005, transcript variant X2
uncharacterized protein LOC125047005 isoform X2
uncharacterized LOC125047005, transcript variant X1
uncharacterized protein LOC125047005 isoform X1
uncharacterized LOC125047006, transcript variant X1
uncharacterized LOC125047006, transcript variant X2
uncharacterized protein LOC125047006 isoform X1
uncharacterized LOC125047006, transcript variant X3
uncharacterized LOC125047006, transcript variant X4
uncharacterized protein LOC125047006 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
oocyte zinc finger protein XlCOF6-like, transcript variant X2
oocyte zinc finger protein XlCOF6-like, transcript variant X3
oocyte zinc finger protein XlCOF6-like, transcript variant X1
oocyte zinc finger protein XlCOF6-like isoform X2
oocyte zinc finger protein XlCOF6-like isoform X3
zinc finger protein ZFP2-like isoform X1
uncharacterized oxidoreductase TM_0325-like
cAMP-dependent protein kinase catalytic subunit 1
similar to RNA sequence (same species):INSD:GIYE01072969.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 184 bases not found in genome assembly
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 19 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
vascular endothelial growth factor A-like
transient receptor potential cation channel subfamily A member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 21% coverage of the annotated genomic feature by RNAseq alignments
aspartate, glycine, lysine and serine-rich protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 31% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125047236, transcript variant X2
uncharacterized LOC125047236, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125047236, transcript variant X3
uncharacterized protein LOC125047236 isoform X2
uncharacterized protein LOC125047236 isoform X1
uncharacterized protein LOC125047236 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 256 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
COORDINATES: nucleotide motif:Rfam:12.0:RF00012